Literature DB >> 25553645

Prevalence and clinical distribution of multidrug-resistant bacteria (3537 isolates) in a tertiary Chinese hospital (January 2012-December 2013).

X-Q Jia1, F Pang2, J-Z Chen1, L-X Jiang1.   

Abstract

OBJECTIVE: Multidrug-resistant organisms (MDROs) have become a widespread serious problem in recent years. Our objective was to determine the prevalence and clinical distribution of MDROs in a tertiary care hospital in China from January 1, 2012 to December 31, 2013.
METHODS: The strains were cultured according to standard methods; bacterial identification and susceptibility testing were detected by Vitek 2 system. The prevalence and clinical distribution of extended-spectrum β-lactamases (ESBLs)-producing enterobacteriaceae, carbapenem-resistant enterobacteriaceae (CRE), multiple-drug/pan-drug resistant P. aeruginosa (MDR/PDR-PA), carbapenem-resistant A. baumannii (CR-AB), methicillin-resistant S. aureus (MRSA) and vancomycin-resistant enterococcus (VRE) were analyzed by WHONET 5.6.
RESULTS: A total of 3537 (33.4%) MDROs were found among 10,594 microbial isolates. ESBLs producing E. coli (ESBLs-ECO) (1153 cases) were the most frequent MDROs, followed by CR-AB (827 cases). The proportion of acquired resistance of A. baumannii (48.9%) accounted for the highest in all the MDROs. These MDROs were mainly isolated from respiratory (70.3%) and secretions (12.7%). Various types of intensive care unit (ICU) and surgery were the main source departments. The proportion of CRE and VRE were relatively few. CRE was most isolated from respiratory tract and closed body cavity fluid, while the distribution of VRE was relatively dispersed.
CONCLUSION: High prevalence of MDROs has emerged in our hospital, particular in various ICU and surgical department. The effective way to prevent the further spread of MDROs is to strengthen the protection of respiratory tract and surgical wounds.
Copyright © 2014. Published by Elsevier SAS.

Entities:  

Keywords:  Distribution; Multidrug-resistant organisms; Organismes multi-résistants; Prevalence; Prévalence

Mesh:

Substances:

Year:  2014        PMID: 25553645     DOI: 10.1016/j.patbio.2014.12.002

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  4 in total

1.  Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013).

Authors:  P J Simner; H Adam; M Baxter; M McCracken; G Golding; J A Karlowsky; K Nichol; P Lagacé-Wiens; M W Gilmour; D J Hoban; G G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

2.  Clinical characteristics and risk factors of enterococcal infections in Nagasaki, Japan: a retrospective study.

Authors:  Toshiki Kajihara; Shigeki Nakamura; Naoki Iwanaga; Kazuhiro Oshima; Takahiro Takazono; Taiga Miyazaki; Koichi Izumikawa; Katsunori Yanagihara; Nobuoki Kohno; Shigeru Kohno
Journal:  BMC Infect Dis       Date:  2015-10-16       Impact factor: 3.090

3.  Methicillin-resistant Staphylococcus aureus nasal colonization and infection in an intensive care unit of a university hospital in China.

Authors:  Fu Qiao; Wenzhi Huang; Lin Cai; Zhiyong Zong; Weijia Yin
Journal:  J Int Med Res       Date:  2018-06-18       Impact factor: 1.671

4.  Application of next generation sequencing-based rapid detection platform for microbiological diagnosis and drug resistance prediction in acute lower respiratory infection.

Authors:  Lingshan Chao; Jihong Li; Ya'nan Zhang; Hao Pu; Xixin Yan
Journal:  Ann Transl Med       Date:  2020-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.